Anticorps Monoclonal anti-LGALS3BP
LGALS3BP Monoclonal Antibody for WB, IHC, IF/ICC, IP, ELISA
Hôte / Isotype
Mouse / IgG2b
Réactivité testée
Humain
Applications
WB, IHC, IF/ICC, IP, ELISA
Conjugaison
Non conjugué
CloneNo.
2D8E11
N° de cat : 60066-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
60066-1-PBS cible LGALS3BP dans les applications de WB, IHC, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Mouse / IgG2b |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | LGALS3BP Protéine recombinante Ag0294 |
| Nom complet | lectin, galactoside-binding, soluble, 3 binding protein |
| Masse moléculaire calculée | 585 aa, 65 kDa |
| Poids moléculaire observé | 65-90 kDa |
| Numéro d’acquisition GenBank | BC002403 |
| Symbole du gène | LGALS3BP |
| Identification du gène (NCBI) | 3959 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Galectin-3-binding protein (LGALS3BP, also known as 90K or Mac-2 BP) is a secreted glycoprotein which binds galectin-3, galectin-1, beta1 integrins, collagens and fibronectin (PMID: 8034587; 8024581; 11146440; 9501082). It has been implicated in tumor metastatic processes, as well as in other cell adhesion and immune functions. Levels of LGALS3BP have been found elevated in the serum of patients with cancer and in those infected by the human immunodeficiency virus (HIV) (PMID: 7698018). Western analysis suggests that LGALS3BP is found in breast milk, semen, saliva, urine, and tears, in addition to serum (PMID: 8390986 ). LGALS3BP has a predicted mass of ∼65 kDa. It is heavily glycosylated and shows an apparent molecular weight of 90 kDa on SDS-PAGE.





























